novo glp-1 drug shows less lean mass loss than rivals, study says Novo Nordisk sees pills capturing

It decreases the production of a hormone that opposes insulin called glucagon

doi:10.1038/cdd.2010.80

It appears on the Prohibited List under Section S2 (Peptide Hormones, Growth Factors, Related Substances, and Mimetics) as a growth hormone-releasing factor

View Source Expert opinion on biological therapy Thymosin 4: a multi-functional regenerative peptide

Key benefits include enhanced exercise performance, improved muscle recovery, potential weight management support, and enhanced brain function

Laboratory research record on GLP-1S [PMID: 33567185] PubMed laboratory record discussing GLP-1S in a research context